Stella Mental Health Secures $5M to Revolutionize Interventional Psychiatry Treatments

Stella Mental Health is thrilled to announce a major milestone in our ongoing mission to transform mental health care by raising $5,000,000 in our latest funding round. As an interventional psychiatry practice, we are dedicated to advancing the understanding and treatment of anxiety, depression, PTSI/PTSD, and other mental health conditions with the same urgency and innovation that our patients deserve. This significant capital influx will empower us to expand our cutting-edge treatment offerings, which include Spravato (esketamine), transcranial magnetic stimulation (TMS), dual sympathetic reset (DSR)—an advanced stellate ganglion block (SGB)—ketamine infusion therapy, as well as comprehensive medication management and integration therapy. The funds raised will be strategically allocated to enhance our clinical research, broaden access to our innovative therapies, and support the development of new interventions that can rapidly improve outcomes for individuals grappling with mental health challenges. By investing in the latest technologies and methodologies, Stella Mental Health is positioning itself at the forefront of interventional psychiatry, ensuring that every innovation we pursue has the potential to save lives. This capital will also allow us to expand our specialized team of healthcare professionals and therapists, increase the capacity of our treatment centers, and broaden our community outreach programs which are essential in reducing the stigma around mental health. This funding round marks a pivotal moment for Stella Mental Health. It reinforces our commitment to providing state-of-the-art, compassionate care and underscores the vital role that advanced, interventional treatments play in tackling some of the most challenging mental health conditions of our time. We are excited about the future and the opportunity to shape a new era in mental health care.